DeepLook Medical
Private Company
Total funding raised: $57M
Overview
DeepLook Medical is a private, commercial-stage diagnostics company leveraging artificial intelligence to revolutionize medical imaging interpretation. Its core product, DL Precise™, is an FDA-cleared software tool that provides one-click segmentation and enhanced visualization of lesions, aiming to improve diagnostic accuracy for radiologists, especially in mammography. The company has established commercial partnerships with leading medical imaging platform providers and is backed by a seasoned leadership team with expertise in medtech, AI, and radiology. DeepLook targets the significant market need for better tools in cancer detection, aiming to reduce unnecessary follow-up procedures and associated costs for the healthcare system.
Technology Platform
AI/ML software platform (DL Precise™) for enhancing resolution and clarity in medical images. Provides one-click segmentation and vivid tumor morphology display, integrating directly into existing radiology workflows.
Funding History
2Opportunities
Risk Factors
Competitive Landscape
DeepLook operates in the highly competitive AI-powered medical imaging diagnostics market. Competitors range from large, established medical imaging OEMs (e.g., GE HealthCare, Siemens Healthineers) integrating AI into their own systems, to independent software vendors like iCAD, Hologic's AI portfolio, and numerous venture-backed startups (e.g., Aidoc, Zebra Medical Vision, Qure.ai). Differentiation hinges on superior algorithm performance, seamless workflow integration, robust clinical evidence, and effective commercialization partnerships.